Kopp Investment Advisors’s Enzo Biochem, Inc. ENZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-25,557
Closed -$133K 60
2018
Q2
$133K Sell
25,557
-129,929
-84% -$792K 0.12% 58
2018
Q1
$852K Sell
155,486
-2,941
-2% -$20.7K 0.87% 37
2017
Q4
$1.29M Sell
158,427
-7,300
-4% -$69.7K 1.29% 29
2017
Q3
$1.74M Sell
165,727
-33,405
-17% -$371K 1.59% 24
2017
Q2
$2.2M Sell
199,132
-43,508
-18% -$405K 1.97% 22
2017
Q1
$2.03M Buy
242,640
+30,666
+14% +$216K 1.99% 20
2016
Q4
$1.47M Sell
211,974
-20,125
-9% -$128K 1.55% 24
2016
Q3
$1.18M Sell
232,099
-452,260
-66% -$2.7M 1.17% 26
2016
Q2
$4.09M Buy
684,359
+196,635
+40% +$1.09M 2.17% 9
2016
Q1
$2.22M Sell
487,724
-103,150
-17% -$459K 1.21% 16
2015
Q4
$2.66M Sell
590,874
-79,153
-12% -$334K 1.31% 19
2015
Q3
$2.12M Sell
670,027
-152,495
-19% -$463K 1.14% 21
2015
Q2
$2.49M Buy
822,522
+171,107
+26% +$481K 1.11% 25
2015
Q1
$1.92M Buy
651,415
+2,015
+0.3% +$6.6K 0.85% 27
2014
Q4
$2.88M Sell
649,400
-10,220
-2% -$48.7K 1.39% 19
2014
Q3
$3.4M Buy
659,620
+187,335
+40% +$999K 1.68% 16
2014
Q2
$2.48M Buy
+472,285
New +$2.04M 1.14% 22

Other funds holding ENZ

Kopp Investment Advisors's ENZ Position: Q3 2018 in Review

Kopp Investment Advisors sold out of Enzo Biochem, Inc. (ENZ) in Q3 2018, closing a stake of 25,557 shares — an estimated $133K sold.

Kopp Investment Advisors first reported a position in ENZ in Q2 2014 and held it in 17 quarters. The position peaked at $4.09M in Q2 2016. 101 funds tracked by Wall St. Rank hold ENZ as of Q3 2018.

  • Kopp Investment Advisors reported no remaining Enzo Biochem, Inc. position as of Q3 2018 after selling out during the quarter.
  • Kopp Investment Advisors sold 25,557 Enzo Biochem, Inc. shares in Q3 2018, an estimated $133K.
  • Kopp Investment Advisors first reported a position in Enzo Biochem, Inc. in Q2 2014 and held it in 17 quarters.
  • Kopp Investment Advisors's Enzo Biochem, Inc. position peaked at $4.09M in Q2 2016.
  • 101 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2018.

Based on Kopp Investment Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.